Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF582 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PPIL4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEC14L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADAMTSL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00474 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SYN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100507513 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL14EP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT16P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPY2R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929762 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBED5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLCA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PFN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BHMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on